Cannabix Technologies Inc (BLOZF)

[medchem]

those who dont believe me should search the board here for his past posts.

^ You have referenced one single users post from many months ago. The reliability is very small to support your claim. The companies opinion changes over time as the product is developed, once they start to realize they have a very valuable technology on hand, they increase their price target. There is no way they would settle for 2-3 dollars. They are trading at 0.80 cents and they haven't even come up with a trial design yet.

you seem to agree though that blozf has to license nanose to get to market... bthcf is leading the way and blozf will follow.

^Yes Breathtec is leading the way, but you haven't got things exactly straight. Breathtec has Na-NOSE and a couple heavy hitters on board that are going to take Na-NOSE to market. They are already enrolling patients in a government approved clinical trial and there stock is EXTREMELY undervalued. It would be EXTREMELY undervalued if all they had was FAIMS. If Breathtec scores on Na-NOSE, it is for certain that money will find it's way to Cannabix, albeit indirecty through Yost. They work on FAIMS for both BLO and BTH in the same lab. They can say it's strictly for BTH, but let's get real, the FAIMS device is shared.